Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
The Journal of Biological Chemistry|July 10, 2001
The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levelsM J Ausserlechner, P Obexer, G J Wiegers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2010
From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancerG D Aletti, D Nordquist, L Hartmann, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1978
Salivary immunoglobulins in progressive systemic sclerosisJ N Fiessinger, J P Camilleri, C Amat, et al.
International Journal of Oncology|June 19, 1998
Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancerA Yokomizo, D J Tindall, L Hartmann, et al.
Gynecologic Oncology|July 1, 1993
Absence of prohibitin gene mutations in human epithelial ovarian tumorsW Cliby, G Sarkar, S R Ritland, et al.
British Journal of Haematology|September 13, 2001
Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cellsM Tiefenthaler, A Amberger, N Bacher, et al.
The Journal of Biological Chemistry|March 30, 2001
The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levelsM J Ausserlechner, P Obexer, G J Wiegers, et al.
Pageof 23